NCT02240732

Brief Summary

BACKGROUND In 2012 76,497 primary total knee (TKR) replacements were performed in England, Wales and Northern Ireland . Traditionally TKR surgery is undertaken with the aid of a surgical tourniquet. A surgical tourniquet is an occlusive device applied around a patient's leg. The tourniquet squeezes the leg (including blood vessels within the leg) and can therefore reduce the amount of bleeding that occurs while it is inflated. An intraoperative tourniquet can therefore help to improve the surgical field of view. Although the majority of surgeons prefer to undertake TKR surgery using a tourniquet a small but increasing number are now not pursuing these devices. There is robust evidence that the risk of deep vein thrombosis is increased if a tourniquet is used for TKR surgery. In addition embolic material in the venous system have been observed following TKR surgery and have been noted to be present in the right atrium with transoesophageal (TOE) echo intra-operatively. , Significant and potentially life threatening emboli have been documented to enter the cerebral circulation via pulmonary arterio-venous shunts and patent foramen ovale (PFO) (27% of patients at autopsy) , . The clinical manifestations of cerebral emboli post tourniquet deflation in TKR are not fully understood. Fat embolism syndrome and post-operative confusion in TKR patients may be the result of emboli formed during a TKR. , AIM

  • Is there evidence of emboli entering the cerebral circulation following tourniquet deflation in TKR surgery?
  • Is there evidence of MRI detectable brain lesions and or any clinical change in cognition compared in patients undergoing TKR surgery with a tourniquet compared to those that do not have a tourniquet?

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Sep 2014

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2014

Completed
14 days until next milestone

First Submitted

Initial submission to the registry

September 15, 2014

Completed
1 day until next milestone

First Posted

Study publicly available on registry

September 16, 2014

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2015

Completed
Last Updated

June 30, 2015

Status Verified

June 1, 2015

Enrollment Period

7 months

First QC Date

September 15, 2014

Last Update Submit

June 28, 2015

Conditions

Outcome Measures

Primary Outcomes (2)

  • Number of Emboli on Transcranial Doppler

    2 independent technicians will verify the number of emboli detected. Non-invasive

    Intra-operative

  • MRI brain scan - presence of Emboli

    Reviewed by Professor of radiology - presence, number and volume of diffusion weighted lesions

    Post-operatively, prior to discharge

Secondary Outcomes (1)

  • Mini-mental state examination

    Pre-operative vs Post-operative

Study Arms (1)

Total knee replacement patients

Patients who are due to have a total knee replacement will be studied to look for the presence of Emboli. Observational with imaging.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients who are due to have a total knee replacement.

You may qualify if:

  • i.Aged \>18
  • ii.Undergoing elective TKR
  • iii.Able to give written informed consent
  • iv.No contraindications to MR imaging

You may not qualify if:

  • i. Ages \<16
  • ii. Not able to give written informed consent
  • iv. Contraindications to MR imaging

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Warwickshire and Coventry

Coventry, CV2 2DX, United Kingdom

Location

Related Publications (7)

  • Tai TW, Lin CJ, Jou IM, Chang CW, Lai KA, Yang CY. Tourniquet use in total knee arthroplasty: a meta-analysis. Knee Surg Sports Traumatol Arthrosc. 2011 Jul;19(7):1121-30. doi: 10.1007/s00167-010-1342-7. Epub 2010 Dec 15.

    PMID: 21161177BACKGROUND
  • Parmet JL, Horrow JC, Pharo G, Collins L, Berman AT, Rosenberg H. The incidence of venous emboli during extramedullary guided total knee arthroplasty. Anesth Analg. 1995 Oct;81(4):757-62. doi: 10.1097/00000539-199510000-00017.

    PMID: 7574006BACKGROUND
  • Parmet JL, Berman AT, Horrow JC, Harding S, Rosenberg H. Thromboembolism coincident with tourniquet deflation during total knee arthroplasty. Lancet. 1993 Apr 24;341(8852):1057-8. doi: 10.1016/0140-6736(93)92414-o.

    PMID: 8096961BACKGROUND
  • Arroyo JS, Garvin KL, McGuire MH. Fatal marrow embolization following a porous-coated bipolar hip endoprosthesis. J Arthroplasty. 1994 Aug;9(4):449-52. doi: 10.1016/0883-5403(94)90057-4.

    PMID: 7964778BACKGROUND
  • Pugsley W, Klinger L, Paschalis C, Treasure T, Harrison M, Newman S. The impact of microemboli during cardiopulmonary bypass on neuropsychological functioning. Stroke. 1994 Jul;25(7):1393-9. doi: 10.1161/01.str.25.7.1393.

    PMID: 8023354BACKGROUND
  • Riding G, Daly K, Hutchinson S, Rao S, Lovell M, McCollum C. Paradoxical cerebral embolisation. An explanation for fat embolism syndrome. J Bone Joint Surg Br. 2004 Jan;86(1):95-8.

    PMID: 14765873BACKGROUND
  • Caillouette JT, Anzel SH. Fat embolism syndrome following the intramedullary alignment guide in total knee arthroplasty. Clin Orthop Relat Res. 1990 Feb;(251):198-9.

    PMID: 2295174BACKGROUND

MeSH Terms

Conditions

OsteoarthritisWounds and Injuries

Condition Hierarchy (Ancestors)

ArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Study Officials

  • Victoria Gibbs, BA, MBBS

    UHCW

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Doctor

Study Record Dates

First Submitted

September 15, 2014

First Posted

September 16, 2014

Study Start

September 1, 2014

Primary Completion

April 1, 2015

Study Completion

April 1, 2015

Last Updated

June 30, 2015

Record last verified: 2015-06

Locations